{"id":265999,"date":"2025-08-18T17:32:50","date_gmt":"2025-08-18T20:32:50","guid":{"rendered":"https:\/\/new.tvpublica.com.ar\/?p=265999"},"modified":"2025-08-18T17:32:50","modified_gmt":"2025-08-18T20:32:50","slug":"la-anmat-prohibio-el-uso-comercializacion-y-distribucion-del-medicamento-ozempic-falsificado","status":"publish","type":"post","link":"https:\/\/test-back.tvpublica.com.ar\/2025\/08\/18\/la-anmat-prohibio-el-uso-comercializacion-y-distribucion-del-medicamento-ozempic-falsificado\/","title":{"rendered":"La ANMAT prohibi\u00f3 el uso, comercializaci\u00f3n y distribuci\u00f3n del medicamento Ozempic falsificado"},"content":{"rendered":"<p>La\u00a0Administraci\u00f3n Nacional de Medicamentos, Alimentos y Tecnolog\u00eda M\u00e9dica (ANMAT)\u00a0prohibi\u00f3 el uso, comercializaci\u00f3n y distribuci\u00f3n en todo el territorio Nacional\u00a0del medicamento Ozempic, fabricado por Pharma Argentina S.A.<\/p>\n<p>En el documento dado a conocer, las autoridades de la ANMAT indicaron que no se podr\u00e1 usar, comercializar y distribuir cualquier dosis, presentaci\u00f3n y lote que se identifique como\u00a0Ozempic\u00ae Semaglutida Tablets USP.<\/p>\n<p>La medida fue tomada tras una denuncia presentada por la firma\u00a0Novo Nordisk Pharma Argentina S.A., titular del registro del medicamento original Ozempic, por la publicaci\u00f3n en redes sociales de dicho producto\u00a0falsificado.<\/p>\n<p>El director t\u00e9cnico de la firma comunic\u00f3 a la Direcci\u00f3n de Evaluaci\u00f3n y Gesti\u00f3n de Monitoreo de Productos para la Salud (DEGMPS) sobre la aparici\u00f3n en redes sociales de\u00a0un producto que declaraba contener semaglutida en comprimidos orales, bajo la denominaci\u00f3n \u201cOzempic Semaglutida Tablets USP, 25 mg, 60 tablets\u201d.<\/p>\n<p>En la presentaci\u00f3n se aport\u00f3 una muestra y se afirm\u00f3 que no existe a nivel mundial un producto Ozempic en forma de comprimidos o c\u00e1psulas, y que el producto exhibido es\u00a0falsificado.<\/p>\n<p>\u201cLa decisi\u00f3n tiene como fin proteger a eventuales adquirentes y usuarios del medicamento involucrado debido a que representa un riesgo para la salud de la poblaci\u00f3n\u201d, destac\u00f3 el escrito.<\/p>\n<p>El Ozempic es\u00a0un medicamento para\u00a0adultos con diabetes tipo 2\u00a0que, junto con dieta y ejercicio,\u00a0puede mejorar el nivel de az\u00facar en la sangre.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Es por una denuncia realizada por el propio laboratorio sobre la aparici\u00f3n en redes sociales de dicho producto falsificado.<\/p>\n","protected":false},"author":40,"featured_media":266001,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"featured_image_url":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","rank_math_robots":"","rank_math_canonical_url":"","tvp_seo_json":"","tvp_ads_json":"","tvp_ads_json_public":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[22,4732],"tags":[6542,11093,33630,31422],"class_list":["post-265999","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias","category-sociedad","tag-anmat","tag-laboratorios","tag-medicamento-falsificado","tag-ozempic"],"seo":{"title":null,"description":null,"focus_keywords":[],"robots":null,"canonical":null,"permalink":"https:\/\/test-back.tvpublica.com.ar\/2025\/08\/18\/la-anmat-prohibio-el-uso-comercializacion-y-distribucion-del-medicamento-ozempic-falsificado\/","rankmath_getHead":"https:\/\/test-back.tvpublica.com.ar\/wp-json\/rankmath\/v1\/getHead?url=https%3A%2F%2Ftest-back.tvpublica.com.ar%2F2025%2F08%2F18%2Fla-anmat-prohibio-el-uso-comercializacion-y-distribucion-del-medicamento-ozempic-falsificado%2F"},"acf":{"display_object":"image","volanta":"Sociedad","background_header":false,"objeto_destacado":false,"gallery":false,"related_posts":[{"posts":""}],"imagenes_mosaico":false},"featured_image_url":"https:\/\/api.tvpublica.com.ar\/wp-content\/uploads\/2025\/08\/Sin-t\u00edtulo-18.png","_links":{"self":[{"href":"https:\/\/test-back.tvpublica.com.ar\/wp-json\/wp\/v2\/posts\/265999","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/test-back.tvpublica.com.ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/test-back.tvpublica.com.ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/test-back.tvpublica.com.ar\/wp-json\/wp\/v2\/users\/40"}],"replies":[{"embeddable":true,"href":"https:\/\/test-back.tvpublica.com.ar\/wp-json\/wp\/v2\/comments?post=265999"}],"version-history":[{"count":1,"href":"https:\/\/test-back.tvpublica.com.ar\/wp-json\/wp\/v2\/posts\/265999\/revisions"}],"predecessor-version":[{"id":266004,"href":"https:\/\/test-back.tvpublica.com.ar\/wp-json\/wp\/v2\/posts\/265999\/revisions\/266004"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/test-back.tvpublica.com.ar\/wp-json\/wp\/v2\/media\/266001"}],"wp:attachment":[{"href":"https:\/\/test-back.tvpublica.com.ar\/wp-json\/wp\/v2\/media?parent=265999"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/test-back.tvpublica.com.ar\/wp-json\/wp\/v2\/categories?post=265999"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/test-back.tvpublica.com.ar\/wp-json\/wp\/v2\/tags?post=265999"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}